Platelet-Rich Plasma Injection / 대한정형외과학회잡지
The Journal of the Korean Orthopaedic Association
; : 381-392, 2018.
Article
in Korean
| WPRIM (Western Pacific)
| ID: wpr-717531
Responsible library:
WPRO
ABSTRACT
Platelet-rich plasma (PRP) supplies numerous growth factors from concentrated platelets required to promote the healing process of injured or degenerated tissue. PRP is already a popular option to treat a variety of musculoskeletal injuries and diseases, even though the precise mechanism of action is not completely understood. Varying outcomes, from favorable to poor, after PRP injection may arise from interstudy differences with respect to 4Ds (Drug [PRP], Delivery [application method], Donor [patients], and Disease [stage of rotator cuff disease]). In addition, there is no standard treatment regimen (injection location, number, interval, volume). Therefore, precise outcome measures as well as long-term follow-up are required to accurately evaluate the efficacy.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Osteoarthritis
/
Tissue Donors
/
Follow-Up Studies
/
Rotator Cuff
/
Outcome Assessment, Health Care
/
Intercellular Signaling Peptides and Proteins
/
Equipment and Supplies
/
Tendinopathy
/
Platelet-Rich Plasma
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
Korean
Journal:
The Journal of the Korean Orthopaedic Association
Year:
2018
Document type:
Article